×
0.0322580645161291 0.0322580645161291 0.0580645161290323 0.161290322580645 0.103225806451613 -0.0258064516129032 -0.0258064516129032 -0.0258064516129032
Stockreport

Data Presented at ECTRIMS 2018 Show Potential of MOSPD2 as a Novel Target for Treatment of CNS Inflammation, Such as Multiple Sclerosis

Vascular Biogenics Ltd Ordina (VBLT)  More Company Research Source: GlobeNewswire
Last vascular biogenics ltd ordina earnings: 11/20 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: vblrx.com
PDF TEL AVIV, Israel, Oct. 11, 2018 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq: VBLT), announced today that a study entitled “MOSPD2: A Novel Therapeutic Target for the Treatment of CNS Inflammation,” is being presented today at the 34th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Berlin, Germany.  The poster is being presented 5:15pm - 7:15pm CEST today, as part of Poster Session 2.  VBL is developing its VB-600 platform of biologics targeting MOSPD2 for inflammatory and oncology indications. In MS, blood-borne monocytes constitute a part of the central nervous system (CNS)-infiltrating cells and are paramount for disease pathogenesis. Therefore, inhibiting monocyte migration to the CNS of MS patients could have a therapeutic benefit. VBL identified MOSPD2 (motile sperm domain–containing protein 2) as a protein which is predominantly expressed on the surface of human monocytes and is essential for their migration. In this study, t [Read more]

IMPACT SNAPSHOT EVENT TIME: VBLT
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
VBLT alerts
from News Quantified
Opt-in for
VBLT alerts

from News Quantified
Opt-in for
VBLT alerts

from News Quantified